These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 23047310)

  • 1. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
    White AA; Stevenson DD
    Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
    Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
    J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
    Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
    Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
    Simon RA; Dazy KM; Waldram JD
    Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
    Krouse HJ; Krouse JH
    ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and salicylate in respiratory disease.
    Mitchell JE; Skypala I
    Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease.
    Pacheco CS; Brooks RM; White KM
    Mil Med; 2023 Jul; 188(7-8):e2826-e2828. PubMed ID: 36383070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.